What is NDC 72865-211?

72865-211 is the product NDC for Lisinopril, Lisinopril 20 mg/1 tablet, listed with the FDA by XLCare Pharmaceuticals Inc.. It has 6 package NDCs, shown above in 10- and 11-digit form.

XLCare Pharmaceuticals Inc., NDC labeler code 72865. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lisinopril?

267 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lisinopril NDC 72865-211 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72865-211Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72865-0211Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
72865-211-01	72865021101	100 TABLET in 1 BOTTLE (72865-211-01)Marketed from Aug 17, 2021
72865-211-10	72865021110	1000 TABLET in 1 BOTTLE (72865-211-10)Marketed from Aug 17, 2021
72865-211-18	72865021118	180 TABLET in 1 BOTTLE (72865-211-18)Marketed from Aug 17, 2021
72865-211-45	72865021145	45 TABLET in 1 BOTTLE (72865-211-45)Marketed from Aug 17, 2021
72865-211-50	72865021150	5000 TABLET in 1 BOTTLE (72865-211-50)Marketed from Aug 17, 2021
72865-211-90	72865021190	90 TABLET in 1 BOTTLE (72865-211-90)Marketed from Aug 17, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lisinopril
Generic name (nonproprietary): lisinopril
Active ingredients: Lisinopril — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: XLCare Pharmaceuticals Inc.NDC labeler code 72865
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075903
Marketing start: Aug 17, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)
Identifiers: Product ID 72865-211_c008ecb6-970d-4ac9-9402-e21e8d9d76b2SPL ID c008ecb6-970d-4ac9-9402-e21e8d9d76b2SPL set ID c008ecb6-970d-4ac9-9402-e21e8d9d76b2RxCUI 197884, 205326, 311353, 311354, 314076, 314077UNII E7199S1YWRUPC 0372865210505, 0372865212059, 0372865211502, 0372865213100
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472865021101 followed by a unit qualifier and the quantity

Package 72865-0211-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 23, 2021. This label includes a boxed warning.

Indications (excerpt from the label)

Lisinopril tablets are an angiotensin converting enzyme (ACE) inhibitor indicated for: • Treatment of hypertension in adults and pediatric patients 6 years of age and older (1.1) • Adjunct therapy for heart failure (1.2) • Treatment of Acute Myocardial Infarction (1.3) 1.1 Hypertension Lisinopril tablets are indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes. …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72865-211

What is NDC 72865-211?: 72865-211 is the product NDC for Lisinopril, Lisinopril 20 mg/1 tablet, listed with the FDA by XLCare Pharmaceuticals Inc.. It has 6 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lisinopril.
What is the active ingredient?: Lisinopril.
Who is the labeler?: XLCare Pharmaceuticals Inc., NDC labeler code 72865. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lisinopril?: 267 other product NDCs are listed under this name. See all Lisinopril NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lisinopril NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lisinopril	Lisinopril 5 mg/1	TabletOral	Coupler LLC	67046-2097	67046-2097-03
Lisinopril	Lisinopril 10 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-047	87441-0047-01
Lisinopril	Lisinopril 20 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-048	87441-0048-01
Lisinopril	Lisinopril 5 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-049	87441-0049-01
Lisinopril	Lisinopril 10 mg/1	TabletOral	Coupler LLC	67046-0422	67046-0422-03
Lisinopril	Lisinopril 20 mg/1	TabletOral	Coupler LLC	67046-0423	67046-0423-03
Lisinopril	Lisinopril 5 mg/1	TabletOral	Coupler LLC	67046-0858	67046-0858-03
lisinopril	Lisinopril 10 mg/1	TabletOral	REMEDYREPACK INC.	70518-4509	70518-4509-00
Lisinopril	Lisinopril 10 mg/1	TabletOral	REMEDYREPACK INC.	70518-4397	70518-4397-00
Lisinopril	Lisinopril 5 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8562	68788-8562-0168788-8562-0368788-8562-06+1 more

All 268 Lisinopril NDCs

Other NDCs under ANDA 075903

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075903
Product	Strength	Form · route	Labeler	Product NDC
Lisinopril	Lisinopril 2.5 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-172
Lisinopril	Lisinopril 2.5 mg/1	TabletOral	Legacy Pharmaceutical Packaging, LLC	68645-608
Lisinopril	Lisinopril 2.5 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-172
Lisinopril	Lisinopril 30 mg/1	TabletOral	Legacy Pharmaceutical Packaging, LLC	68645-612
Lisinopril	Lisinopril 10 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-177
Lisinopril	Lisinopril 5 mg/1	TabletOral	Legacy Pharmaceutical Packaging, LLC	68645-609
Lisinopril	Lisinopril 10 mg/1	TabletOral	Legacy Pharmaceutical Packaging, LLC	68645-610
Lisinopril	Lisinopril 5 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-176
Lisinopril	Lisinopril 20 mg/1	TabletOral	Legacy Pharmaceutical Packaging, LLC	68645-611
Lisinopril	Lisinopril 5 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-176
Lisinopril	Lisinopril 30 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-179
Lisinopril	Lisinopril 10 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-177
Lisinopril	Lisinopril 40 mg/1	TabletOral	Legacy Pharmaceutical Packaging, LLC	68645-613
Lisinopril	Lisinopril 20 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-178
Lisinopril	Lisinopril 20 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-178
Lisinopril	Lisinopril 30 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-179
Lisinopril	Lisinopril 40 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-180
Lisinopril	Lisinopril 40 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-180
Lisinopril	Lisinopril 5 mg/1	TabletOral	XLCare Pharmaceuticals Inc.	72865-209
Lisinopril	Lisinopril 2.5 mg/1	TabletOral	XLCare Pharmaceuticals Inc.	72865-208

Showing 20 of 23.